medical treatment of celiac disease

... Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disor- ders in Celiac Disease. Gastroenterology ... Prevalence of celiac disease in a sample of Turkish children and adoles- cents with type 1 diabetes mellitus. J Clin Gastroenterol 2006; 40: 655-7. 4. Tanure MG, Silva IN, Bahia M, et al. Prevalence of ... Development of ce- liac disease- associated antibodies in offspring of parents with type I diabetes. Diabetologia 2000; 43: 1005-11. 7. Jaeger C, Hatziagelaki E, Petzoldt R, et al. Comparative analysis of...

Ngày tải lên: 05/03/2014, 12:20

... Igs found in the serum of celiac disease patients. Keywords: autoimmunity; celiac disease; transglutaminase; epitope mapping; phage display. Celiac disease (CD) is a genetic disease strongly linked ... Greco, L. (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology ... Schematic drawing of the cloning of 12 different tTG regions. Reference numbers of the amino acid residues at the ends of the cloned sequences are shown. Ó FEBS 2002 Epitope mapping of anti-tTG Igs...

Ngày tải lên: 08/03/2014, 09:20

Ngày tải lên: 22/03/2014, 13:20

Ngày tải lên: 20/06/2014, 07:20

Ngày tải lên: 08/08/2014, 21:20

Ngày tải lên: 09/08/2014, 06:22

... insufficient treatment of AF or, on the contrary, is caused by adverse effects of the treatment, however, is too realistic to be ignored. All we have stated about the treatment of AF in MICU ... Netherlands 2 Department of Intensive Care, University Medical Center Groningen, University of Groningen, PO 30.001, 9700 RB Groningen, The Netherlands 3 Department of Intensive Care, University Hospital VU Medical ... disease and other nosocomial complications. Can treatment of atrial fibrillation improve survival? There are few data on the effect of treatment of AF on mortality in ICU patients. A meta-analysis...

Ngày tải lên: 25/10/2012, 10:35

... notion of medical futility’ as an end-stage process in which vital signs cannot be supported further is poorly understood by both physicians and surrogates [13]. In fact, any medical treatment ... for medically inappropriate care. They simply should not be offered inappropriate end -of- life care. Second, we should strive to emphasize what Streat and coworkers [15] termed, ‘the large risk of ... than death, and many of them occur in ICUs when futility maxims are circumvented. There is a population of ICU patients who will die no matter what treatment is rendered them. Medically inappropriate...

Ngày tải lên: 25/10/2012, 10:45

... [29] Initiation of Treatment ã Baseline fasting glucose level First Year of Treatment ã Fasting glucose level every 34 months ã Observe for signs of hyperglycemia Duration of Treatment ã Fasting ... discussion: Common medical comorbidities and treatment- emergent illnesses, including obesity, diabetes mellitus, dyslipidemia, cardiac disease, hepatic disease, renal disease, pulmonary disease and ... mellitusdyslipidemiacardiac diseasehepatic diseaserenal diseasepulmonary diseasecancer-mood stabilizersanticonvulsantsatypical antipsychotics Abstract Background: The pharmacological treatment of bipolar disorder...

Ngày tải lên: 25/10/2012, 10:51

... decreased risk of aging, chronic disease, or cancer chemopre- vention and treatment in the general population. 11.3 Parkinson’s Disease Parkinson’s disease (also known as Parkinson disease or PD) ... fallen out of use by 1745 due to inappropriate use (Wilkins et al., 1985). Dr. William Withering introduced foxglove back to the medical profession in An Account of the Foxglove and Some of Its Medical ... nor study subject can influ- ence, or bias, the assessment of the effect of the treatment on disease outcome. RCT study design features of particular importance include the following: an appropriate and...

Ngày tải lên: 25/10/2013, 05:20

... emerging targets for treatment of obesity and related metabolic diseases Tsuyoshi Kadomatsu, Mitsuhisa Tabata and Yuichi Oike Department of Molecular Genetics, Graduate School of Medical Sciences, ... with increased risk of cardiovascular disease, the leading cause of death. Therefore, it is important to understand the molecular basis underly- ing obesity and related metabolic diseases in order ... roles of ANGPTL2 and ANGPTL6 ⁄ AGF in obesity and related metabolic diseases, and discuss the possibility that both could func- tion as molecular targets for the prevention and treatment of obesity...

Ngày tải lên: 14/02/2014, 22:20

... Department of Medical Biophysics, University of Toronto, Canada 4 Department of Laboratory Medicine and Pathology, University of Toronto, Canada 5 Department of Biochemistry, University of Toronto, ... indicate the feasibility of using inhibition of MDR1 as an approach to the treatment of Fabry disease. Although the efficacy may not, as yet, be as dramatic as ERT, inhibition of MDR1 may prove most ... overnight with 2 mL of chloroform ⁄ methanol (2 : 1 v ⁄ v) per 100 lL of plasma and then partitioned against 1 ⁄ 5 volume of water. The lower phase was dried under a stream of nitrogen gas and...

Ngày tải lên: 19/02/2014, 07:20

... effectiveness of hydroxyurea treatment of hematologic diseases, the toxicity of hydroxyurea in the treatment of any disease, and the barriers to the treatment of sickle cell disease with hydroxyurea ... long-term harms of its use in patients with sickle cell disease and other diseases, and to discuss barriers to the use of hydroxyurea and other medications in the treatment of sickle cell disease. ... with Treatment for Patients with Sickle Cell Disease 61 Table 9. Summary of Barriers to Treatment of Sickle Cell Disease Reported by Patients and Providers 63 Table 10. Results of Studies...

Ngày tải lên: 05/03/2014, 10:20

... Collateralization of Striatofugal Neurons and Co-localization of Dopamine Receptors One of the important series of data that challenged the concept of segregated direct and indirect striatofugal pathways ... UK U N JUNG KANG, MD ã Department of Neurology, The University of Chicago, Chicago, IL M ICHAEL KAPLITT, MD, PhD ã Department of Neurosurgery, Weill Medical College of Cornell University, New York, ... Neurology, University of Kansas Medical Center, Kansas City, KS N ORA PAPASIAN, PhD ã Department of Neurology, The University of Chicago, Chicago, IL S IMON PARKIN, MRCP ã Department of Neurology, The...

Ngày tải lên: 05/03/2014, 23:20

... completion of 2 months of treatment, the continuation phase of treatment should consist of isoniazid and rifampin daily or twice weekly for 4 months to complete a total of 6 months of treatment. ... the strength of treatment recommendations based on quality of evidence* Strength of the recommendation A. Preferred; should generally be offered B. Alternative; acceptable to offer C. Offer when ... Management of Patients at Increased Risk of Relapse The result of a sputum culture at the conclusion of the ini- tial phase of treatment (2 months) has been shown to corre- late with the likelihood of...

Ngày tải lên: 06/03/2014, 04:20

... management. Unfortunately,fearandlack of knowledgeabouttheuse of opioidsinchildrenaswellasinadultsare oftenabarriertotherelief of pain.Theefcacy of strongopioidsintherelief of painisestablished; indirect ... (13).As such,althoughanatomicalclassicationscanbeusefulfordifferentialdiagnoses,theseclassicationsdo not offer a framework for clinical management of pain. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses > 16 1 CLASSIFICATION OF PAIN ... performance. However,childrenmaydisplaynoneoftheexpectedcues.Theymaydenytheirpainforfearofmore painfultreatment,forexample,theymaybefearfulofinjections.Absenceofthesesignsdoesnotmean absence of pain and care should...

Ngày tải lên: 07/03/2014, 04:20

... ameliorate several of the dysfunctional events characteristic of Alzheimer’s disease. Metal-based therapeutics have already provided promising results for the treatment of Alzheimer’s disease, and ... therapeutic strategy for the treatment of Alzheimer’s disease Peter J. Crouch 1 , Anthony R. White 1 and Ashley I. Bush 2,3 1 Department of Pathology and Centre for Neuroscience, The University of Melbourne, ... development of effective therapeutic strategies is hampered by a paucity of information on the biolo- gical mechanisms underlying the disease. The severity of AD relates to a multitude of age-related...

Ngày tải lên: 07/03/2014, 10:20